Latest Commentary




Raymond Chan, Head of Asian Desk at Morgans, is again a fan of Resmed (RMD). In our “HOT STOCK” column today, Raymond goes through the reasons why he continues to believe RMD is an ADD to an inves..

Full Article >

Anecdotal evidence from many tourism operators points to Aussie travellers rethinking travel plans to travel at home – where the Australian dollar will always be an Australian dollar. Here are two p..

Full Article >

In our “HOT STOCK” column today, Raymond Chan, Head of Asian Desk, gives us a rundown on what tariffs apply to various pharma stocks and which pharma he sees as an ADD to an investor’s portfolio..

Full Article >